Review demonstrates altered lipid profiles across CETP genetic variants, indicating that targeted CETP inhibition may modify cardiovascular risk independent of statin efficacy.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Boekholdt et al. (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: